Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology

Radiol Med. 2022 May;127(5):543-559. doi: 10.1007/s11547-022-01471-y. Epub 2022 Mar 20.

Abstract

Smoking is the main risk factor for lung cancer (LC), which is the leading cause of cancer-related death worldwide. Independent randomized controlled trials, governmental and inter-governmental task forces, and meta-analyses established that LC screening (LCS) with chest low dose computed tomography (LDCT) decreases the mortality of LC in smokers and former smokers, compared to no-screening, especially in women. Accordingly, several Italian initiatives are offering LCS by LDCT and smoking cessation to about 10,000 high-risk subjects, supported by Private or Public Health Institutions, envisaging a possible population-based screening program. Because LDCT is the backbone of LCS, Italian radiologists with LCS expertise are presenting this position paper that encompasses recommendations for LDCT scan protocol and its reading. Moreover, fundamentals for classification of lung nodules and other findings at LDCT test are detailed along with international guidelines, from the European Society of Thoracic Imaging, the British Thoracic Society, and the American College of Radiology, for their reporting and management in LCS. The Italian College of Thoracic Radiologists produced this document to provide the basics for radiologists who plan to set up or to be involved in LCS, thus fostering homogenous evidence-based approach to the LDCT test over the Italian territory and warrant comparison and analyses throughout National and International practices.

Keywords: Computed tomography; Computer assisted diagnosis; Early diagnosis; Lung cancer; Lung nodule; Screening.

MeSH terms

  • Early Detection of Cancer / methods
  • Female
  • Humans
  • Lung Neoplasms* / diagnostic imaging
  • Mass Screening
  • Radiography, Thoracic
  • Radiology*
  • Tomography, X-Ray Computed / methods